Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...
Proponents of the plan to equip paramedics with buprenorphine call it the "missing link" in the bridge to recovery for many ...
Rather than further criminalizing substance use disorder, we must legitimize trauma-informed care as a key pathway to ending ...
The unprecedented increase in drug overdose deaths in the U.S., long believed to be driven by access to legal and illegal ...
For people who study the opioid epidemic, 2025 marks a grim anniversary: It has been 30 years since the Food and Drug ...
A movie filmed in eastern Kentucky last summer is making the rounds in movie theatres all over the world. The movie is called ...
Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage, director of population health at Englewood Hospital, discuss what ...
A new "powerful tool" for combatting opioid deaths isn't settled science. For that reason, the state is taking a measured ...
The agreement also ends the Sacklers’ control of Purdue Pharma and prohibits them from selling opioids in the United States.
Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion ...
A new database tracks how state and local governments across the country are spending billions of dollars in opioid ...
The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...